Gene symbol |
Time course plot |
Accession |
Description |
Treatment |
15min |
30min |
1hr |
2hr |
4hr |
8hr |
20hr |
Adh1 |  |
AK082149 |
0 day neonate cerebellum cDNA, RIKEN full-length enriched library, clone:C230014D21 product:unclassifiable, full insert sequence [AK082149] |
KLA | .94 |
.96 |
.97 |
.95 |
1.01 |
.95 |
.96 |
| ATP | .99 |
1.05 |
.93 |
.91 |
1.02 |
1.04 |
1.00 |
| KLA/ATP | .87 |
.88 |
.94 |
.92 |
.86 |
1.04 |
.93 |
|
Adh1 |  |
NM_007409 |
alcohol dehydrogenase 1 (class I) (Adh1), mRNA [NM_007409] |
KLA | 1.02 |
.98 |
.96 |
1.04 |
1.01 |
1.04 |
1.08 |
| ATP | .96 |
1.03 |
1.00 |
1.03 |
1.05 |
1.01 |
1.04 |
| KLA/ATP | 1.02 |
1.03 |
1.04 |
1.01 |
1.04 |
1.09 |
1.04 |
|
Adh4 |  |
NM_011996 |
alcohol dehydrogenase 4 (class II), pi polypeptide (Adh4), mRNA [NM_011996] |
KLA | .95 |
.94 |
.93 |
1.07 |
1.04 |
.96 |
.99 |
| ATP | .95 |
.95 |
.95 |
.99 |
1.02 |
.93 |
.97 |
| KLA/ATP | 1.03 |
1.02 |
.92 |
.97 |
1.02 |
1.01 |
.99 |
|
Adh5 |  |
NM_007410 |
alcohol dehydrogenase 5 (class III), chi polypeptide (Adh5), mRNA [NM_007410] |
KLA | .93 |
.76 |
.71 |
.83 |
.61 |
.63 |
.76 |
| ATP | 1.02 |
.98 |
1.19 |
1.06 |
1.08 |
.85 |
.86 |
| KLA/ATP | .77 |
.76 |
1.06 |
.86 |
.87 |
.84 |
.62 |
|
Adh7 |  |
NM_009626 |
alcohol dehydrogenase 7 (class IV), mu or sigma polypeptide (Adh7), mRNA [NM_009626] |
KLA | 1.07 |
1.01 |
1.02 |
.98 |
1.03 |
.99 |
1.01 |
| ATP | 1.03 |
1.09 |
1.02 |
1.08 |
1.03 |
1.09 |
1.01 |
| KLA/ATP | 1.10 |
1.03 |
1.06 |
1.02 |
1.05 |
1.06 |
1.13 |
|
Aldh1a1 |  |
NM_013467 |
aldehyde dehydrogenase family 1, subfamily A1 (Aldh1a1), mRNA [NM_013467] |
KLA | 1.06 |
.95 |
1.04 |
1.03 |
.98 |
1.08 |
1.07 |
| ATP | .94 |
1.03 |
1.01 |
1.00 |
1.00 |
1.07 |
.99 |
| KLA/ATP | 1.03 |
.98 |
1.02 |
1.01 |
1.05 |
1.05 |
1.02 |
|
Aldh1a2 |  |
NM_009022 |
aldehyde dehydrogenase family 1, subfamily A2 (Aldh1a2), mRNA [NM_009022] |
KLA | 1.10 |
1.09 |
1.04 |
1.05 |
1.16 |
1.14 |
1.06 |
| ATP | 1.03 |
1.02 |
1.03 |
.99 |
1.04 |
1.07 |
1.02 |
| KLA/ATP | 1.04 |
1.10 |
1.02 |
1.15 |
1.33 |
1.26 |
1.01 |
|
Aldh1a7 |  |
NM_011921 |
aldehyde dehydrogenase family 1, subfamily A7 (Aldh1a7), mRNA [NM_011921] |
KLA | 1.06 |
1.00 |
.97 |
1.04 |
1.05 |
1.03 |
.96 |
| ATP | 1.00 |
.94 |
1.04 |
1.06 |
1.01 |
1.00 |
1.05 |
| KLA/ATP | 1.06 |
.94 |
1.07 |
1.10 |
1.23 |
1.08 |
1.09 |
|
Aox1 |  |
NM_009676 |
aldehyde oxidase 1 (Aox1), mRNA [NM_009676] |
KLA | .87 |
.83 |
.82 |
.82 |
.71 |
.98 |
1.65 |
| ATP | 1.01 |
1.02 |
1.05 |
.84 |
.72 |
.86 |
.80 |
| KLA/ATP | .82 |
.84 |
.90 |
.73 |
.72 |
.82 |
1.06 |
|
Aox3 |  |
NM_023617 |
aldehyde oxidase 3 (Aox3), mRNA [NM_023617] |
KLA | .95 |
1.02 |
1.01 |
1.00 |
.99 |
1.01 |
1.04 |
| ATP | 1.04 |
1.03 |
1.01 |
.94 |
1.03 |
.92 |
.96 |
| KLA/ATP | 1.09 |
1.11 |
1.00 |
.97 |
.95 |
1.01 |
.94 |
|
Aox4 |  |
NM_023631 |
aldehyde oxidase 4 (Aox4), mRNA [NM_023631] |
KLA | .95 |
.97 |
.98 |
1.00 |
.98 |
.91 |
1.06 |
| ATP | .93 |
.99 |
.95 |
.99 |
.94 |
.95 |
1.00 |
| KLA/ATP | 1.05 |
1.00 |
.94 |
.98 |
.89 |
1.00 |
.93 |
|
Bcmo1 |  |
NM_021486 |
beta-carotene 15,15-monooxygenase (Bcmo1), mRNA [NM_021486] |
KLA | 1.05 |
.97 |
1.02 |
1.07 |
1.00 |
1.04 |
1.15 |
| ATP | .96 |
.98 |
1.03 |
1.06 |
.98 |
1.05 |
1.02 |
| KLA/ATP | 1.01 |
1.03 |
1.08 |
1.09 |
1.03 |
1.09 |
1.03 |
|
Cyp1a1 |  |
NM_009992 |
cytochrome P450, family 1, subfamily a, polypeptide 1 (Cyp1a1), mRNA [NM_009992] |
KLA | 1.07 |
.99 |
1.02 |
1.01 |
1.00 |
1.00 |
1.11 |
| ATP | .99 |
1.02 |
1.01 |
.95 |
.96 |
.94 |
1.09 |
| KLA/ATP | 1.01 |
1.03 |
.98 |
.96 |
.96 |
.95 |
1.51 |
|
Cyp1a2 |  |
NM_009993 |
cytochrome P450, family 1, subfamily a, polypeptide 2 (Cyp1a2), mRNA [NM_009993] |
KLA | 1.01 |
.99 |
.98 |
1.02 |
.97 |
.97 |
1.00 |
| ATP | 1.01 |
.98 |
1.03 |
1.01 |
1.04 |
1.02 |
1.04 |
| KLA/ATP | .99 |
1.00 |
1.05 |
1.03 |
.98 |
.97 |
.99 |
|
Cyp26a1 |  |
NM_007811 |
cytochrome P450, family 26, subfamily a, polypeptide 1 (Cyp26a1), mRNA [NM_007811] |
KLA | 1.22 |
1.12 |
1.21 |
1.25 |
1.07 |
1.13 |
1.11 |
| ATP | .99 |
.94 |
1.11 |
1.09 |
1.05 |
1.13 |
.99 |
| KLA/ATP | 1.28 |
1.33 |
1.36 |
2.76 |
3.25 |
1.75 |
1.20 |
|
Cyp26b1 |  |
NM_175475 |
cytochrome P450, family 26, subfamily b, polypeptide 1 (Cyp26b1), mRNA [NM_175475] |
KLA | 1.11 |
1.11 |
.98 |
.96 |
1.03 |
.97 |
.94 |
| ATP | 1.03 |
1.01 |
1.05 |
.92 |
1.01 |
1.49 |
1.20 |
| KLA/ATP | 1.04 |
.99 |
1.02 |
.95 |
.99 |
1.17 |
1.31 |
|
Cyp2a12 |  |
NM_133657 |
cytochrome P450, family 2, subfamily a, polypeptide 12 (Cyp2a12), mRNA [NM_133657] |
KLA | 1.03 |
1.08 |
1.00 |
.98 |
1.00 |
1.03 |
1.03 |
| ATP | 1.01 |
.98 |
1.03 |
1.08 |
1.02 |
.99 |
1.01 |
| KLA/ATP | .97 |
1.01 |
.97 |
1.06 |
1.03 |
1.03 |
.99 |
|
Cyp2a4 |  |
NM_009997 |
cytochrome P450, family 2, subfamily a, polypeptide 4 (Cyp2a4), mRNA [NM_009997] |
KLA | 1.02 |
.99 |
1.00 |
1.00 |
.98 |
1.04 |
1.01 |
| ATP | 1.01 |
1.00 |
1.01 |
1.03 |
.99 |
1.01 |
.99 |
| KLA/ATP | 1.03 |
1.03 |
1.01 |
1.04 |
.98 |
1.03 |
1.01 |
|
Cyp2a5 |  |
NM_007812 |
cytochrome P450, family 2, subfamily a, polypeptide 5 (Cyp2a5), mRNA [NM_007812] |
KLA | 1.04 |
.95 |
.95 |
1.02 |
1.01 |
.94 |
1.06 |
| ATP | 1.03 |
.95 |
1.05 |
1.08 |
.99 |
.97 |
1.03 |
| KLA/ATP | 1.01 |
1.06 |
.92 |
1.08 |
1.05 |
1.01 |
1.01 |
|
Cyp2b10 |  |
NM_009999 |
cytochrome P450, family 2, subfamily b, polypeptide 10 (Cyp2b10), transcript variant 2, mRNA [NM_009999] |
KLA | .98 |
1.03 |
.97 |
1.02 |
1.02 |
.97 |
1.03 |
| ATP | 1.03 |
.99 |
1.02 |
1.02 |
.98 |
1.02 |
.99 |
| KLA/ATP | 1.04 |
1.00 |
1.02 |
.93 |
.97 |
.93 |
.91 |
|
Cyp2b13 |  |
NM_007813 |
cytochrome P450, family 2, subfamily b, polypeptide 13 (Cyp2b13), mRNA [NM_007813] |
KLA | .99 |
1.02 |
1.00 |
1.06 |
1.05 |
1.03 |
.99 |
| ATP | .96 |
.96 |
.96 |
.98 |
.99 |
.95 |
.98 |
| KLA/ATP | 1.00 |
1.03 |
1.04 |
1.02 |
1.01 |
1.06 |
.99 |
|
Cyp2b19 |  |
AK029227 |
0 day neonate head cDNA, RIKEN full-length enriched library, clone:4831430P04 product:cytochrome P450, 2b19, full insert sequence. [AK029227] |
KLA | .96 |
.98 |
1.02 |
1.09 |
1.06 |
1.00 |
1.08 |
| ATP | 1.02 |
1.06 |
.91 |
1.05 |
1.00 |
.97 |
.95 |
| KLA/ATP | .99 |
.93 |
.96 |
1.03 |
1.00 |
1.04 |
1.00 |
|
Cyp2b19 |  |
NM_007814 |
cytochrome P450, family 2, subfamily b, polypeptide 19 (Cyp2b19), mRNA [NM_007814] |
KLA | 1.14 |
1.20 |
1.18 |
1.17 |
1.17 |
1.21 |
1.14 |
| ATP | .96 |
1.01 |
1.11 |
1.08 |
.99 |
1.08 |
1.10 |
| KLA/ATP | 1.09 |
1.05 |
1.17 |
1.16 |
1.16 |
1.10 |
1.07 |
|
Cyp2b23 |  |
NM_001081148 |
cytochrome P450, family 2, subfamily b, polypeptide 23 (Cyp2b23), mRNA [NM_001081148] |
KLA | 1.09 |
.96 |
1.01 |
.95 |
.97 |
1.01 |
.92 |
| ATP | .97 |
1.00 |
.92 |
.92 |
.98 |
.97 |
.94 |
| KLA/ATP | 1.01 |
1.02 |
1.03 |
.94 |
.94 |
.93 |
.97 |
|
Cyp2b9 |  |
NM_010000 |
cytochrome P450, family 2, subfamily b, polypeptide 9 (Cyp2b9), mRNA [NM_010000] |
KLA | .99 |
1.00 |
1.02 |
1.01 |
1.03 |
.98 |
1.03 |
| ATP | 1.01 |
.98 |
.97 |
.98 |
1.01 |
.96 |
.98 |
| KLA/ATP | 1.00 |
1.04 |
.94 |
1.04 |
1.02 |
1.03 |
.99 |
|
Cyp2c29 |  |
NM_007815 |
cytochrome P450, family 2, subfamily c, polypeptide 29 (Cyp2c29), mRNA [NM_007815] |
KLA | 1.01 |
.95 |
1.06 |
1.12 |
1.01 |
1.02 |
1.12 |
| ATP | 1.03 |
1.02 |
1.01 |
1.06 |
.98 |
.98 |
.96 |
| KLA/ATP | 1.09 |
1.14 |
1.02 |
.98 |
.99 |
.98 |
.98 |
|
Cyp2c37 |  |
NM_010001 |
cytochrome P450, family 2. subfamily c, polypeptide 37 (Cyp2c37), mRNA [NM_010001] |
KLA | 1.27 |
1.43 |
1.64 |
1.52 |
1.65 |
1.43 |
1.45 |
| ATP | .99 |
.96 |
1.03 |
1.13 |
1.10 |
1.03 |
1.27 |
| KLA/ATP | 1.37 |
1.49 |
1.22 |
1.46 |
1.16 |
1.12 |
1.24 |
|
Cyp2c38 |  |
NM_010002 |
cytochrome P450, family 2, subfamily c, polypeptide 38 (Cyp2c38), mRNA [NM_010002] |
KLA | 1.01 |
1.06 |
.98 |
.96 |
1.07 |
.98 |
.97 |
| ATP | 1.01 |
1.09 |
1.04 |
.98 |
1.00 |
1.03 |
.98 |
| KLA/ATP | 1.03 |
.98 |
1.03 |
1.04 |
1.00 |
1.00 |
1.01 |
|
Cyp2c39 |  |
NM_010003 |
cytochrome P450, family 2, subfamily c, polypeptide 39 (Cyp2c39), mRNA [NM_010003] |
KLA | 1.04 |
1.01 |
.97 |
1.00 |
.99 |
1.01 |
.98 |
| ATP | 1.04 |
1.07 |
.95 |
1.00 |
.96 |
1.03 |
1.01 |
| KLA/ATP | 1.03 |
1.01 |
1.02 |
1.01 |
1.05 |
1.05 |
.99 |
|
Cyp2c40 |  |
NM_010004 |
cytochrome P450, family 2, subfamily c, polypeptide 40 (Cyp2c40), mRNA [NM_010004] |
KLA | .96 |
1.06 |
1.05 |
1.03 |
.99 |
1.01 |
1.02 |
| ATP | .96 |
1.01 |
1.02 |
.97 |
1.01 |
1.02 |
.99 |
| KLA/ATP | 1.06 |
1.03 |
1.04 |
.98 |
1.05 |
1.01 |
.97 |
|
Cyp2c44 |  |
NM_001001446 |
cytochrome P450, family 2, subfamily c, polypeptide 44 (Cyp2c44), mRNA [NM_001001446] |
KLA | .98 |
1.04 |
.93 |
1.05 |
1.01 |
.93 |
.94 |
| ATP | 1.02 |
1.01 |
1.01 |
1.04 |
1.02 |
1.02 |
1.00 |
| KLA/ATP | .93 |
.95 |
1.00 |
1.05 |
1.07 |
1.01 |
1.01 |
|
Cyp2c54 |  |
NM_206537 |
cytochrome P450, family 2, subfamily c, polypeptide 54 (Cyp2c54), mRNA [NM_206537] |
KLA | .98 |
.99 |
1.04 |
.97 |
1.06 |
1.03 |
1.04 |
| ATP | .99 |
.98 |
1.10 |
1.03 |
1.03 |
.98 |
1.03 |
| KLA/ATP | 1.02 |
1.04 |
.89 |
.98 |
.99 |
.93 |
.99 |
|
Cyp2c55 |  |
NM_028089 |
cytochrome P450, family 2, subfamily c, polypeptide 55 (Cyp2c55), mRNA [NM_028089] |
KLA | .97 |
1.02 |
1.01 |
.99 |
.99 |
1.00 |
.94 |
| ATP | 1.04 |
.98 |
1.09 |
.97 |
1.05 |
.99 |
1.06 |
| KLA/ATP | 1.04 |
1.01 |
1.15 |
1.03 |
1.05 |
1.05 |
1.09 |
|
Cyp2c65 |  |
AK008688 |
adult male stomach cDNA, RIKEN full-length enriched library, clone:2210009K14 product:similar to CYTOCHROME P450 2C18 (EC 1.14.14.1) (CYPIIC18) (P450-6B [AK008688] |
KLA | .95 |
.97 |
1.02 |
1.00 |
.97 |
1.10 |
1.04 |
| ATP | .98 |
1.05 |
1.00 |
1.10 |
.98 |
.99 |
1.03 |
| KLA/ATP | .96 |
.97 |
.99 |
1.01 |
1.03 |
1.04 |
1.03 |
|
Cyp2c66 |  |
NM_001011707 |
cytochrome P450, family 2, subfamily c, polypeptide 66 (Cyp2c66), mRNA [NM_001011707] |
KLA | 1.03 |
1.04 |
.99 |
1.00 |
1.06 |
1.11 |
1.01 |
| ATP | .97 |
1.01 |
1.03 |
1.00 |
.98 |
1.03 |
1.04 |
| KLA/ATP | 1.08 |
.97 |
1.15 |
1.02 |
1.04 |
1.06 |
1.08 |
|
Cyp2c70 |  |
NM_145499 |
cytochrome P450, family 2, subfamily c, polypeptide 70 (Cyp2c70), mRNA [NM_145499] |
KLA | 1.05 |
.94 |
.95 |
.86 |
1.06 |
.96 |
.99 |
| ATP | 1.01 |
.98 |
.69 |
.69 |
.97 |
.87 |
1.09 |
| KLA/ATP | 1.00 |
.97 |
.74 |
.74 |
.81 |
.86 |
1.17 |
|
Cyp3a11 |  |
NM_007818 |
cytochrome P450, family 3, subfamily a, polypeptide 11 (Cyp3a11), mRNA [NM_007818] |
KLA | .96 |
.94 |
1.06 |
1.04 |
.96 |
.94 |
.97 |
| ATP | 1.00 |
1.01 |
.94 |
.95 |
.94 |
.92 |
.98 |
| KLA/ATP | .98 |
1.06 |
1.06 |
.98 |
.88 |
.93 |
.91 |
|
Cyp3a13 |  |
NM_007819 |
cytochrome P450, family 3, subfamily a, polypeptide 13 (Cyp3a13), mRNA [NM_007819] |
KLA | .99 |
.98 |
.98 |
1.03 |
.97 |
1.01 |
1.07 |
| ATP | 1.00 |
1.01 |
1.01 |
1.04 |
1.01 |
.99 |
1.00 |
| KLA/ATP | 1.06 |
1.01 |
1.00 |
1.08 |
1.09 |
1.01 |
1.09 |
|
Cyp3a16 |  |
NM_007820 |
cytochrome P450, family 3, subfamily a, polypeptide 16 (Cyp3a16), mRNA [NM_007820] |
KLA | .95 |
.99 |
.96 |
.96 |
1.00 |
1.03 |
.99 |
| ATP | 1.04 |
1.03 |
.98 |
.97 |
.98 |
1.03 |
1.01 |
| KLA/ATP | .96 |
.91 |
.96 |
.97 |
1.03 |
1.00 |
1.04 |
|
Cyp3a25 |  |
NM_019792 |
cytochrome P450, family 3, subfamily a, polypeptide 25 (Cyp3a25), mRNA [NM_019792] |
KLA | 1.00 |
.96 |
1.01 |
1.04 |
.99 |
.99 |
1.01 |
| ATP | 1.01 |
1.02 |
.97 |
1.01 |
1.02 |
.93 |
.95 |
| KLA/ATP | .97 |
1.09 |
1.04 |
1.01 |
.99 |
.97 |
.97 |
|
Cyp3a41a
|  |
NM_017396 |
cytochrome P450, family 3, subfamily a, polypeptide 41A (Cyp3a41a), mRNA [NM_017396] |
KLA | 1.02 |
.99 |
.98 |
.95 |
.93 |
.93 |
1.06 |
| ATP | 1.00 |
.96 |
1.02 |
.97 |
.97 |
.95 |
1.02 |
| KLA/ATP | 1.03 |
1.02 |
1.07 |
.97 |
.93 |
.97 |
.97 |
|
Cyp3a44 |  |
NM_177380 |
cytochrome P450, family 3, subfamily a, polypeptide 44 (Cyp3a44), mRNA [NM_177380] |
KLA | 1.05 |
1.03 |
1.05 |
1.02 |
1.08 |
1.00 |
1.03 |
| ATP | .97 |
1.00 |
1.03 |
1.07 |
.99 |
.99 |
.99 |
| KLA/ATP | 1.04 |
.99 |
.99 |
1.06 |
1.04 |
1.06 |
1.00 |
|
Cyp4a10 |  |
NM_010011 |
cytochrome P450, family 4, subfamily a, polypeptide 10 (Cyp4a10), mRNA [NM_010011] |
KLA | 1.14 |
1.13 |
1.13 |
1.13 |
1.15 |
1.12 |
1.06 |
| ATP | 1.02 |
1.01 |
1.09 |
1.03 |
1.10 |
1.11 |
1.00 |
| KLA/ATP | 1.09 |
1.11 |
1.36 |
1.23 |
1.25 |
1.09 |
1.02 |
|
Cyp4a10 |  |
X71478 |
gb|M.musculus Cyp4a-10 mRNA. [X71478] |
KLA | .94 |
.97 |
.93 |
1.01 |
1.01 |
1.09 |
1.26 |
| ATP | .96 |
1.07 |
1.04 |
1.18 |
.88 |
.77 |
1.18 |
| KLA/ATP | 1.00 |
.99 |
.98 |
.98 |
.84 |
.80 |
1.24 |
|
Cyp4a12a
|  |
NM_177406 |
cytochrome P450, family 4, subfamily a, polypeptide 12a (Cyp4a12a), mRNA [NM_177406] |
KLA | 1.08 |
1.04 |
1.02 |
1.06 |
.98 |
1.05 |
1.05 |
| ATP | .98 |
1.00 |
1.10 |
.99 |
.96 |
1.04 |
.98 |
| KLA/ATP | 1.07 |
1.05 |
1.11 |
.96 |
1.06 |
1.02 |
.97 |
|
Cyp4a12b
|  |
NM_172306 |
cytochrome P450, family 4, subfamily a, polypeptide 12B (Cyp4a12b), mRNA [NM_172306] |
KLA | 1.03 |
1.05 |
.95 |
.99 |
.94 |
1.02 |
1.12 |
| ATP | .93 |
.99 |
.95 |
1.00 |
.93 |
.95 |
1.01 |
| KLA/ATP | .98 |
1.01 |
1.09 |
1.00 |
.90 |
.91 |
.93 |
|
Cyp4a14 |  |
NM_007822 |
cytochrome P450, family 4, subfamily a, polypeptide 14 (Cyp4a14), mRNA [NM_007822] |
KLA | .99 |
1.00 |
1.00 |
.97 |
.96 |
.97 |
1.01 |
| ATP | .95 |
.95 |
.93 |
.90 |
.93 |
.99 |
1.03 |
| KLA/ATP | .97 |
.99 |
1.04 |
.93 |
.95 |
.96 |
.97 |
|
Cyp4a29 |  |
NM_001100183 |
cytochrome P450, family 4, subfamily a, polypeptide 29 (Cyp4a29), mRNA [NM_001100183] |
KLA | .94 |
.98 |
1.04 |
1.00 |
.98 |
1.06 |
1.03 |
| ATP | 1.01 |
1.02 |
1.03 |
1.02 |
1.01 |
1.02 |
.97 |
| KLA/ATP | 1.05 |
1.09 |
1.03 |
1.03 |
.97 |
1.02 |
.91 |
|
Cyp4a31 |  |
NM_201640 |
cytochrome P450, family 4, subfamily a, polypeptide 31 (Cyp4a31), mRNA [NM_201640] |
KLA | 1.14 |
.99 |
1.00 |
.98 |
1.06 |
1.03 |
.96 |
| ATP | 1.01 |
1.05 |
1.04 |
.91 |
.98 |
.99 |
.99 |
| KLA/ATP | .99 |
1.03 |
1.04 |
.99 |
.95 |
.97 |
1.06 |
|
Dgat1 |  |
NM_010046 |
diacylglycerol O-acyltransferase 1 (Dgat1), mRNA [NM_010046] |
KLA | 1.05 |
1.03 |
1.09 |
.93 |
1.04 |
1.06 |
1.42 |
| ATP | 1.06 |
1.12 |
1.23 |
1.57 |
1.34 |
2.37 |
1.50 |
| KLA/ATP | 1.11 |
1.10 |
.97 |
1.24 |
1.10 |
2.12 |
2.03 |
|
Dgat2l4 |  |
NM_177746 |
diacylglycerol O-acyltransferase 2-like 4 (Dgat2l4), mRNA [NM_177746] |
KLA | 1.12 |
1.13 |
1.13 |
1.07 |
1.12 |
1.02 |
.98 |
| ATP | 1.01 |
1.01 |
1.04 |
1.08 |
.93 |
.93 |
.93 |
| KLA/ATP | 1.16 |
1.15 |
1.09 |
1.04 |
.99 |
1.00 |
1.02 |
|
Dhrs3 |  |
NM_011303 |
dehydrogenase/reductase (SDR family) member 3 (Dhrs3), mRNA [NM_011303] |
KLA | .40 |
.37 |
.41 |
.39 |
.50 |
.67 |
.72 |
| ATP | 1.15 |
1.16 |
.94 |
1.04 |
.84 |
.34 |
.92 |
| KLA/ATP | .47 |
.44 |
.35 |
.40 |
.48 |
.49 |
.89 |
|
Dhrs4 |  |
NM_030686 |
dehydrogenase/reductase (SDR family) member 4 (Dhrs4), transcript variant 2, mRNA [NM_030686] |
KLA | .94 |
1.05 |
1.17 |
.99 |
.96 |
.84 |
.74 |
| ATP | 1.03 |
1.09 |
1.11 |
1.45 |
1.11 |
.79 |
.88 |
| KLA/ATP | 1.10 |
1.17 |
1.19 |
1.38 |
1.09 |
.87 |
.69 |
|
Dhrs9 |  |
AK089247 |
NOD-derived CD11c +ve dendritic cells cDNA, RIKEN full-length enriched library, clone:F630104J01 product:RETINOL DEHYDROGENASE HOMOLOG ISOFORM-2 homolog [Homo sapiens], full insert sequence [AK089247] |
KLA | 1.17 |
1.17 |
1.22 |
1.43 |
1.27 |
1.05 |
.64 |
| ATP | 1.09 |
1.08 |
1.50 |
1.44 |
1.47 |
1.25 |
2.42 |
| KLA/ATP | 1.06 |
1.17 |
1.87 |
1.67 |
1.52 |
1.25 |
1.91 |
|
Dhrs9 |  |
NM_175512 |
dehydrogenase/reductase (SDR family) member 9 (Dhrs9), mRNA [NM_175512] |
KLA | 1.04 |
1.13 |
1.20 |
1.23 |
1.16 |
1.05 |
1.00 |
| ATP | 1.04 |
1.21 |
1.12 |
1.45 |
1.05 |
1.06 |
2.49 |
| KLA/ATP | 1.13 |
1.25 |
1.10 |
1.35 |
.98 |
1.26 |
1.97 |
|
Hsd17b6 |  |
NM_013786 |
hydroxysteroid (17-beta) dehydrogenase 6 (Hsd17b6), mRNA [NM_013786] |
KLA | .97 |
1.03 |
.99 |
1.00 |
1.02 |
.96 |
1.02 |
| ATP | .96 |
1.04 |
.94 |
.97 |
.97 |
1.04 |
1.01 |
| KLA/ATP | .89 |
.99 |
1.03 |
.94 |
.98 |
.98 |
.95 |
|
Lrat |  |
NM_023624 |
lecithin-retinol acyltransferase (phosphatidylcholine-retinol-O-acyltransferase) (Lrat), mRNA [NM_023624] |
KLA | 1.01 |
.98 |
1.00 |
1.00 |
.96 |
1.01 |
1.00 |
| ATP | .97 |
1.05 |
1.04 |
1.04 |
1.00 |
1.06 |
1.01 |
| KLA/ATP | .99 |
1.04 |
1.00 |
1.01 |
1.06 |
1.00 |
1.00 |
|
Mm.13170 8 |  |
147902088 |
Unknown |
KLA | .96 |
.95 |
.97 |
1.02 |
1.00 |
.99 |
.94 |
| ATP | .98 |
1.00 |
.98 |
1.02 |
.95 |
.98 |
1.02 |
| KLA/ATP | 1.06 |
1.04 |
.99 |
1.02 |
.96 |
.92 |
1.06 |
|
Mm.26719
|  |
23680951 |
Unknown |
KLA | .97 |
.96 |
.93 |
1.05 |
.94 |
1.09 |
.99 |
| ATP | .96 |
1.00 |
1.02 |
1.02 |
1.01 |
1.04 |
.94 |
| KLA/ATP | 1.13 |
1.02 |
.97 |
1.00 |
1.09 |
1.05 |
1.08 |
|
Mm.29467 8 |  |
124487254 |
Unknown |
KLA | 1.01 |
1.07 |
1.03 |
.98 |
1.02 |
1.09 |
1.02 |
| ATP | 1.02 |
1.00 |
1.02 |
1.08 |
.96 |
1.04 |
.97 |
| KLA/ATP | 1.01 |
1.00 |
1.05 |
1.05 |
1.01 |
1.06 |
1.01 |
|
Mm.30009 5 |  |
145699117 |
Unknown |
KLA | .70 |
.74 |
.85 |
.84 |
.90 |
.85 |
.90 |
| ATP | .83 |
.77 |
.93 |
.98 |
1.05 |
1.04 |
.86 |
| KLA/ATP | .72 |
.70 |
.86 |
.97 |
1.13 |
.80 |
.83 |
|
Mm.38984 8 |  |
116268117 |
Unknown |
KLA | .98 |
1.02 |
1.01 |
1.05 |
.97 |
.97 |
.96 |
| ATP | .95 |
1.01 |
1.04 |
1.14 |
.99 |
.91 |
1.01 |
| KLA/ATP | 1.08 |
.92 |
1.02 |
1.00 |
.97 |
.97 |
.99 |
|
Mm.42607 7 |  |
58743309 |
Unknown |
KLA | .98 |
.93 |
1.04 |
1.03 |
.97 |
.98 |
1.16 |
| ATP | 1.02 |
.95 |
1.02 |
1.06 |
.96 |
.95 |
1.04 |
| KLA/ATP | .98 |
.97 |
.98 |
1.01 |
.99 |
1.11 |
.91 |
|
Mm.43985 6 |  |
94421441 |
Unknown |
KLA | 2.04 |
1.82 |
1.94 |
1.90 |
2.06 |
2.47 |
1.41 |
| ATP | 1.28 |
1.23 |
1.50 |
1.05 |
1.09 |
1.00 |
.71 |
| KLA/ATP | 2.17 |
2.09 |
2.44 |
1.31 |
1.47 |
1.32 |
1.66 |
|
Mm.44829 2 |  |
86198313 |
Unknown |
KLA | 1.12 |
1.03 |
1.02 |
1.14 |
1.04 |
1.07 |
1.02 |
| ATP | .95 |
.98 |
1.18 |
1.06 |
1.12 |
1.07 |
1.04 |
| KLA/ATP | 1.04 |
1.15 |
1.29 |
1.11 |
1.16 |
1.21 |
1.14 |
|
Mm.46661 0 |  |
82894546 |
Unknown |
KLA | .86 |
.90 |
.99 |
.94 |
1.02 |
.83 |
.91 |
| ATP | 1.10 |
1.04 |
1.04 |
1.15 |
1.03 |
.93 |
.84 |
| KLA/ATP | .86 |
.85 |
1.00 |
1.10 |
.94 |
.85 |
.90 |
|
Mm.46685 9 |  |
145699102 |
Unknown |
KLA | .65 |
.64 |
.75 |
.87 |
.83 |
.79 |
.82 |
| ATP | .80 |
.77 |
.97 |
.86 |
1.13 |
1.05 |
.85 |
| KLA/ATP | .64 |
.65 |
.85 |
.86 |
1.16 |
.69 |
.72 |
|
Mm.98096
|  |
32526862 |
Unknown |
KLA | .96 |
.99 |
1.01 |
.95 |
.98 |
.95 |
.98 |
| ATP | .97 |
.95 |
.96 |
.95 |
.97 |
.94 |
1.04 |
| KLA/ATP | .95 |
1.02 |
.99 |
1.03 |
.96 |
.96 |
.98 |
|
RP23-24J 10.7 |  |
NM_181989 |
retinal short chain dehydrogenase reductase 2 (Rdhe2), mRNA [NM_181989] |
KLA | 1.03 |
.99 |
1.03 |
.99 |
1.01 |
1.01 |
1.03 |
| ATP | .99 |
.98 |
.95 |
1.04 |
.98 |
.94 |
1.01 |
| KLA/ATP | 1.03 |
1.04 |
1.00 |
1.03 |
1.09 |
.97 |
.76 |
|
Rdh10 |  |
NM_133832 |
retinol dehydrogenase 10 (all-trans) (Rdh10), mRNA [NM_133832] |
KLA | .87 |
.88 |
.87 |
.75 |
.59 |
.46 |
.52 |
| ATP | 1.08 |
1.16 |
1.00 |
1.60 |
1.16 |
.96 |
.56 |
| KLA/ATP | .90 |
.91 |
.84 |
1.31 |
1.09 |
.86 |
.69 |
|
Rdh11 |  |
AY039032 |
short-chain dehydrogenase/reductase (Psdr1) mRNA, complete cds. [AY039032] |
KLA | .94 |
.90 |
.94 |
.87 |
.74 |
.68 |
.77 |
| ATP | .91 |
.93 |
1.39 |
1.14 |
1.38 |
2.76 |
.84 |
| KLA/ATP | .87 |
.90 |
1.20 |
.93 |
1.15 |
1.57 |
1.18 |
|
Rdh11 |  |
NM_021557 |
retinol dehydrogenase 11 (Rdh11), mRNA [NM_021557] |
KLA | 1.11 |
1.06 |
1.22 |
1.17 |
1.02 |
.87 |
1.00 |
| ATP | 1.11 |
1.06 |
1.48 |
1.56 |
1.69 |
2.35 |
1.27 |
| KLA/ATP | 1.22 |
1.21 |
1.37 |
1.51 |
1.44 |
1.47 |
1.83 |
|
Rdh12 |  |
NM_030017 |
retinol dehydrogenase 12 (Rdh12), mRNA [NM_030017] |
KLA | 1.52 |
1.36 |
1.48 |
1.52 |
1.49 |
1.57 |
1.11 |
| ATP | .97 |
1.02 |
1.33 |
1.50 |
1.84 |
1.82 |
1.23 |
| KLA/ATP | 1.36 |
1.45 |
1.97 |
2.02 |
2.30 |
2.27 |
1.89 |
|
Rdh16 |  |
NM_009040 |
retinol dehydrogenase 16 (Rdh16), mRNA [NM_009040] |
KLA | 1.03 |
1.04 |
1.01 |
.98 |
.90 |
.98 |
.98 |
| ATP | 1.05 |
.96 |
1.04 |
1.04 |
.94 |
.98 |
.96 |
| KLA/ATP | 1.08 |
1.03 |
.99 |
.97 |
.72 |
.98 |
.94 |
|
Rdh5 |  |
NM_134006 |
retinol dehydrogenase 5 (Rdh5), mRNA [NM_134006] |
KLA | 1.81 |
1.78 |
1.83 |
1.96 |
1.93 |
2.11 |
1.39 |
| ATP | 1.37 |
1.24 |
1.50 |
1.08 |
1.14 |
1.04 |
.66 |
| KLA/ATP | 2.25 |
2.34 |
2.43 |
1.17 |
1.45 |
1.42 |
1.68 |
|
Retsat |  |
NM_026159 |
retinol saturase (all trans retinol 13,14 reductase) (Retsat), mRNA [NM_026159] |
KLA | 1.03 |
1.02 |
1.00 |
.82 |
.89 |
.64 |
.67 |
| ATP | 1.20 |
1.30 |
1.05 |
1.35 |
1.07 |
.65 |
.50 |
| KLA/ATP | 1.15 |
1.26 |
.90 |
1.18 |
.71 |
.54 |
.51 |
|
Rpe65 |  |
NM_029987 |
retinal pigment epithelium 65 (Rpe65), mRNA [NM_029987] |
KLA | 1.07 |
.99 |
1.00 |
.97 |
1.00 |
.99 |
.98 |
| ATP | .99 |
1.01 |
.98 |
1.06 |
1.03 |
.99 |
1.02 |
| KLA/ATP | .96 |
1.00 |
.96 |
1.01 |
1.20 |
1.00 |
1.01 |
|
Ugt1a1 |  |
NM_201645 |
UDP glucuronosyltransferase 1 family, polypeptide A1 (Ugt1a1), mRNA [NM_201645] |
KLA | .95 |
1.07 |
1.00 |
.99 |
.97 |
.98 |
1.02 |
| ATP | 1.08 |
.95 |
1.02 |
1.04 |
1.08 |
1.03 |
1.01 |
| KLA/ATP | 1.02 |
.95 |
.93 |
1.01 |
1.01 |
1.11 |
1.06 |
|
Ugt1a6b |  |
NM_201410 |
UDP glucuronosyltransferase 1 family, polypeptide A6B (Ugt1a6b), mRNA [NM_201410] |
KLA | .89 |
.86 |
.93 |
.93 |
.89 |
.86 |
.89 |
| ATP | 1.10 |
1.05 |
1.15 |
1.07 |
1.01 |
.99 |
1.24 |
| KLA/ATP | .90 |
.94 |
1.02 |
.89 |
.87 |
.81 |
.92 |
|
Ugt1a9 |  |
NM_201644 |
UDP glucuronosyltransferase 1 family, polypeptide A9 (Ugt1a9), mRNA [NM_201644] |
KLA | 1.07 |
.96 |
.98 |
1.09 |
1.03 |
1.06 |
1.08 |
| ATP | 1.04 |
.94 |
1.01 |
1.07 |
1.05 |
1.02 |
1.06 |
| KLA/ATP | 1.05 |
1.00 |
.94 |
1.01 |
1.03 |
1.04 |
1.00 |
|
Ugt2a1 |  |
NM_053184 |
UDP glucuronosyltransferase 2 family, polypeptide A1 (Ugt2a1), mRNA [NM_053184] |
KLA | 1.01 |
1.03 |
.99 |
.99 |
.99 |
1.01 |
1.02 |
| ATP | 1.01 |
.93 |
1.04 |
1.03 |
1.02 |
1.01 |
1.03 |
| KLA/ATP | 1.04 |
1.01 |
1.01 |
1.02 |
1.01 |
1.02 |
1.00 |
|
Ugt2a3 |  |
NM_028094 |
UDP glucuronosyltransferase 2 family, polypeptide A3 (Ugt2a3), mRNA [NM_028094] |
KLA | 1.07 |
1.01 |
.97 |
1.05 |
1.01 |
.98 |
.99 |
| ATP | .98 |
.96 |
1.04 |
1.06 |
.95 |
.94 |
1.01 |
| KLA/ATP | 1.02 |
1.00 |
.94 |
1.02 |
1.02 |
1.01 |
1.06 |
|
Ugt2b1 |  |
NM_152811 |
UDP glucuronosyltransferase 2 family, polypeptide B1 (Ugt2b1), mRNA [NM_152811] |
KLA | 1.08 |
1.01 |
.95 |
1.08 |
1.00 |
1.04 |
.97 |
| ATP | 1.03 |
1.14 |
1.01 |
1.00 |
1.01 |
1.05 |
1.13 |
| KLA/ATP | 1.05 |
.99 |
1.06 |
.98 |
1.03 |
.96 |
.98 |
|
Ugt2b34 |  |
NM_153598 |
UDP glucuronosyltransferase 2 family, polypeptide B34 (Ugt2b34), mRNA [NM_153598] |
KLA | .98 |
1.08 |
.99 |
1.06 |
.97 |
1.05 |
1.03 |
| ATP | 1.06 |
1.04 |
.96 |
1.01 |
1.03 |
1.01 |
.99 |
| KLA/ATP | 1.09 |
.94 |
1.00 |
1.07 |
1.01 |
1.03 |
.97 |
|
Ugt2b35 |  |
NM_172881 |
UDP glucuronosyltransferase 2 family, polypeptide B35 (Ugt2b35), mRNA [NM_172881] |
KLA | .99 |
1.02 |
.99 |
1.01 |
1.00 |
.96 |
1.01 |
| ATP | .96 |
1.02 |
1.02 |
.96 |
.93 |
1.00 |
1.02 |
| KLA/ATP | 1.01 |
.99 |
1.04 |
1.00 |
.97 |
.93 |
.97 |
|
Ugt2b36 |  |
NM_001029867 |
UDP glucuronosyltransferase 2 family, polypeptide B36 (Ugt2b36), mRNA [NM_001029867] |
KLA | .95 |
.95 |
1.00 |
1.00 |
1.03 |
1.02 |
.92 |
| ATP | 1.02 |
1.07 |
1.03 |
.95 |
1.01 |
.93 |
1.00 |
| KLA/ATP | .99 |
1.05 |
.98 |
1.04 |
1.02 |
.98 |
.99 |
|
Ugt2b37 |  |
NM_053215 |
UDP glucuronosyltransferase 2 family, polypeptide B37 (Ugt2b37), mRNA [NM_053215] |
KLA | 1.02 |
1.06 |
1.04 |
1.05 |
1.00 |
1.05 |
1.03 |
| ATP | 1.01 |
1.03 |
1.08 |
1.01 |
1.05 |
1.02 |
1.05 |
| KLA/ATP | 1.01 |
.99 |
1.11 |
1.14 |
1.04 |
1.08 |
1.05 |
|
Ugt2b38 |  |
NM_133894 |
UDP glucuronosyltransferase 2 family, polypeptide B38 (Ugt2b38), mRNA [NM_133894] |
KLA | 1.00 |
.96 |
1.04 |
.99 |
1.10 |
.97 |
.99 |
| ATP | 1.02 |
1.04 |
1.03 |
.94 |
.96 |
.93 |
.99 |
| KLA/ATP | .98 |
.97 |
1.00 |
.97 |
.98 |
1.04 |
1.02 |
|
Ugt2b5 |  |
NM_009467 |
UDP glucuronosyltransferase 2 family, polypeptide B5 (Ugt2b5), mRNA [NM_009467] |
KLA | 1.01 |
.99 |
1.09 |
.96 |
.97 |
.99 |
1.01 |
| ATP | 1.03 |
1.02 |
1.02 |
1.01 |
.97 |
.90 |
.94 |
| KLA/ATP | .99 |
.99 |
.98 |
1.05 |
1.01 |
.93 |
.95 |
|